Trulieve Cannabis Corp. (NYSE:TRLV – Get Free Report) was the recipient of a large decrease in short interest in October. As of October 30th, there was short interest totaling 3,841,922 shares, a decrease of 47.1% from the October 15th total of 7,259,177 shares. Based on an average daily volume of 1,140,524 shares, the short-interest ratio is presently 3.4 days. Currently, 2.1% of the shares of the company are short sold.
Institutional Investors Weigh In On Trulieve Cannabis
Several institutional investors have recently bought and sold shares of TRLV. Integrated Wealth Concepts LLC purchased a new stake in Trulieve Cannabis in the 3rd quarter valued at about $110,000. EWA LLC bought a new stake in Trulieve Cannabis in the 3rd quarter valued at about $330,000. Diversify Wealth Management LLC purchased a new stake in shares of Trulieve Cannabis during the 3rd quarter valued at approximately $331,000. Aristides Capital LLC purchased a new position in shares of Trulieve Cannabis in the third quarter valued at $259,000. Finally, Lighthouse Investment Partners LLC purchased a new stake in shares of Trulieve Cannabis in the third quarter worth about $282,000.
Trulieve Cannabis Price Performance
Shares of TRLV stock traded up $0.07 on Wednesday, reaching $10.14. 514,678 shares of the company were exchanged, compared to its average volume of 997,162. The firm has a 50-day simple moving average of $11.05. The stock has a market capitalization of $1.73 billion and a P/E ratio of 50.88. The company has a current ratio of 5.52, a quick ratio of 3.65 and a debt-to-equity ratio of 0.45. Trulieve Cannabis has a one year low of $4.62 and a one year high of $13.28.
Trulieve Cannabis (NYSE:TRLV – Get Free Report) last issued its earnings results on Thursday, November 5th. The company reported $0.09 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.09. The company had revenue of $230.20 million for the quarter, compared to analyst estimates of $221.79 million. Trulieve Cannabis had a negative return on equity of 0.34% and a negative net margin of 41.22%. As a group, sell-side analysts predict that Trulieve Cannabis will post 0.13 EPS for the current year.
Wall Street Analysts Forecast Growth
A number of brokerages recently commented on TRLV. Wall Street Zen cut Trulieve Cannabis from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $15.00 price target on shares of Trulieve Cannabis in a research note on Monday, November 2nd. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Trulieve Cannabis in a research note on Friday, September 11th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Trulieve Cannabis has a consensus rating of “Hold” and a consensus price target of $15.00.
Check Out Our Latest Report on TRLV
Trulieve Cannabis Company Profile
Trulieve Cannabis Corp. is a U.S. cannabis company that cultivates, processes and sells cannabis products through a vertically integrated business. Its offerings include flower, concentrates, vape products, edibles and other cannabis products, sold under brands such as Trulieve and Modern Flower. Founded in Florida in 2015, the company built its business in that state and expanded into other U.S. markets, including Arizona and Pennsylvania. Its operations and product offerings are shaped by the regulations in each state where it operates.
Recommended Stories
- Five stocks we like better than Trulieve Cannabis
- SpaceX’s Wild Ride Puts 2 Space Stocks and a Weekly-Payout ETF in Focus
- Palantir’s Political Controversy Is Hiding a Much Bigger Story
- General Motors Faces a Cost Squeeze as Factory Automation Takes Center Stage
- 5 Consumer Discretionary Plays Showing Strength During the Tech Sell-Off
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
